NZYM B Novozymes A/S Class B

Transactions under Novonesis’ share buyback program

Transactions under Novonesis’ share buyback program

As of June 20th, 2025, Novonesis has purchased an accumulated 1,660,344 shares with a transaction value of DKK 713,0 million under the share buyback program announced by Novonesis in Company announcement No. 3, 2025 and initiated on March 5, 2025. Under the program, Novonesis will buy back B shares worth up to EUR 100 million (DKK 746 million) in total during the remainder of 2025.

Please read the full announcement in PDF 

Attachment



EN
23/06/2025

Underlying

NZYM BNovozymes A/S Class B

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Novozymes A/S Class B

 PRESS RELEASE
Free
NZYM B Novozymes A/S C...

Novonesis Hosts National Flagship Manufacturing Day Event at North Ame...

Novonesis Hosts National Flagship Manufacturing Day Event at North America Headquarters Franklinton, NC, Oct. 06, 2025 (GLOBE NEWSWIRE) -- , a global leader in biosolutions, welcomed hundreds of local students, educators, and community leaders to its facilities in Salem, Virginia; West Allis and Madison, Wisconsin; and its North American headquarters in Franklinton, North Carolina, for the national flagship (MFG Day), a grassroots movement of the (MI). The MI is the workforce development and education affiliate of (NAM). The MI’s mission is to build and strengthen the manufacturing workfo...

October 6, 2025 1 EN
 PRESS RELEASE
Free
NZYM B Novozymes A/S C...

Major shareholder announcement

Major shareholder announcement Please read the full announcement in PDF Attachments

September 10, 2025 1 EN
 PRESS RELEASE
Free
NZYM B Novozymes A/S C...

Novonesis and Novo Nordisk will explore new solutions to improve metab...

Novonesis and Novo Nordisk will explore new solutions to improve metabolic health Novonesis and Novo Nordisk join forces in a new research collaboration to explore solutions that seek to preserve and optimize metabolic health and well-being for people. COPENHAGEN, Denmark – September 8, 2025. Novonesis and Novo Nordisk has entered a research partnership to explore the role of the gut microbiome in the maintenance of metabolic health. The gut microbiome is the collection of microorganisms, such as bacteria, fungi, and viruses, that naturally live in the human gut. The science...

September 8, 2025 1 EN
 PRESS RELEASE
Free
NZYM B Novozymes A/S C...

Trading by management and close relations of management

Trading by management and close relations of management Please read the announcement in PDF Attachment

September 2, 2025 1 EN
 PRESS RELEASE
Free
NZYM B Novozymes A/S C...

Amendment: Trading by management and close relations of management

Amendment: Trading by management and close relations of management Please read the announcement in PDF Attachment

August 28, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch